Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
clinical trials
biotech
boston blog main
fda
boston top stories
national top stories
amgen
eli lilly
new york blog main
new york top stories
san francisco blog main
boston
deals
indiana blog main
indiana top stories
new york
novartis
san francisco top stories
alnylam pharmaceuticals
avapritinib
blueprint medicines
calcitonin gene-related peptide
cholesterol
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
genentech
inclisiran
investing
medullary thyroid cancer
non-small cell lung cancer
pcsk9 inhibitors
pralsetinib
regeneron pharmaceuticals
roche
san diego blog main
What
drug
11
×
fda
11
×
medicines
11
×
approval
new
approved
cholesterol
lowering
blueprint
cancer
class
developed
food
genetic
medco
migraine
nod
pain
prevent
regulatory
ret
starts
targeted
therapeutics
wave
wins
won
acquire
ad
address
administration
advisory
affects
age
ago
agreed
akcea
alnylam
americans
amgen
Language
unset
Current search:
drug
×
medicines
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@slashgear.com
4 years ago
Fake coronavirus cures targeted by feds as infections rise
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol